News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Conference News AHA 2023 Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics Todd Neale November 11, 2023
News Daily News FDA Grants Tirzepatide a New Indication for Obesity Management L.A. McKeown November 08, 2023
News Conference News ESC 2023 STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function Shelley Wood August 25, 2023
News Daily News Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs Michael O'Riordan July 11, 2023
News Daily News Vegan Soul Food Study Raises Interesting Questions About ‘Healthy’ Diets L.A. McKeown January 18, 2023